Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5616926 | 0.99 | TLR7 (0.65) | TLR7TLR8 | |
| SCHEMBL5617073 | 0.94 | TLR7 (0.67) | TLR7TLR8 | |
| SCHEMBL5616933 | 0.94 | TLR7 (0.69) | TLR7TLR8 | |
| SCHEMBL5616967 | 0.93 | TLR7 (0.67) | TLR7TLR8 | |
| SCHEMBL5617065 | 0.89 | TLR7 (0.69) | TLR7TLR8 | |
| SCHEMBL5617135 | 0.88 | TLR7 (0.63) | TLR7TLR8 | |
| SCHEMBL5616930 | 0.88 | TLR7 (0.77) | TLR7TLR8 | |
| SCHEMBL5616968 | 0.88 | TLR7 (0.63) | TLR7TLR8 | |
| SCHEMBL4155419 | 0.87 | TLR7 (0.62) | TLR7TLR8 | |
| SCHEMBL4139104 | 0.87 | TLR7 (0.66) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10071156-B2 | Aqueous gel formulations containing immune response modifiers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-09-11 | — | — | US | claimed |
| US-20160101173-A1 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-04-14 | — | — | US | claimed |
| EP-1844201-A2 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-10-17 | — | — | EP | claimed |
| WO-2006084251-A2 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE REPONSE MODIFIERS | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-10071156-B2 | Aqueous gel formulations containing immune response modifiers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-09-11 | — | — | US | disclosed |
| EP-1844201-B1 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-08-24 | — | — | EP | disclosed |
| US-20160101173-A1 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-04-14 | — | — | US | disclosed |
| US-9248127-B2 | Aqueous gel formulations containing immune response modifiers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-02-02 | — | — | US | disclosed |
| US-20090163532-A1 | Aqueous Gel Formulations Containing Immune Response Modifiers | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2009-06-25 | — | — | US | disclosed |
| EP-1844201-A2 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-10-17 | — | — | EP | disclosed |
| US-20070219196-A1 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2007-09-20 | — | — | US | disclosed |
| US-20070219196-A1 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2007-09-20 | — | — | US | disclosed |
| WO-2006084251-A2 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE REPONSE MODIFIERS | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2006-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10071156-B2 | Aqueous gel formulations containing immune response modifiers | IFNG, ICOS, IL4 | TLR7 28/4885TLR8 94/4885 |
| US-20070219196-A1 | AMIDE SUBSTITUTED IMIDAZOPYRIDINES, IMIDAZOQUINOLINES, AND IMIDAZONAPHTHYRIDINES | IL2, IL4, IFNG | TLR7 123/4885TLR8 150/4885 |
| US-20090163532-A1 | Aqueous Gel Formulations Containing Immune Response Modifiers | IFNG, ICOS, IL4 | TLR7 28/4885TLR8 94/4885 |
| US-20160101173-A1 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | IFNG, ICOS, IL4 | TLR7 28/4885TLR8 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.